NCT03710252View on ClinicalTrials.gov

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Chronic Hepatitis C
Interventions
DRUG

paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin

OMB/PTV/r + DSV +/- RBV

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

American Research Corporation

NETWORK